Zevra To Appeal EMA's Negative Opinion On Arimoclomol For Niemann-Pick Disease Type C

India, July 25 -- Zevra Therapeutics, Inc. (ZVRA) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the ... Read More

WSP Raises Arcadis Acquisition Offer To €51.50 After Initial Rejection

India, July 24 -- Friday, WSP Global Inc. (WSP.TO) confirmed that it has made an indicative proposal to the Executive Board and Supervisory Board of Arcadis N.V., recommending public offer for the ent... Read More

Outlook's LYTENAVA Crosses The FDA Finish Line On Its Fourth Attempt - Now Comes The Commercial Test

India, July 24 -- The FDA has approved Outlook Therapeutics Inc.'s (OTLK) NS-5010/LYTENAVA for the treatment of neovascular age-related macular degeneration, commonly known as wet AMD. Wet age-relate... Read More

HCA Healthcare Stock Rises 3% On Higher Q2 Earnings And Revenue

India, July 24 -- HCA Healthcare, Inc. (HCA) shares gained $12.13, or 3.22 percent, to $388.63 on Friday, after the hospital operator reported higher second-quarter earnings and revenue and reaffirmed... Read More

U.S. Stocks Moving Mostly Higher, Partly Offsetting Yesterday's Sell-Off

India, July 24 -- Stocks showed a lack of direction early in the session but have moved mostly higher over the course of the trading day on Friday. The major averages have all climbed into positive te... Read More

FDA Clears Kenvue's TYLENOL With Naproxen, First OTC Fixed-Dose Combination

India, July 24 -- Kenvue Inc. (KVUE) announced that the FDA has approved TYLENOL with Naproxen, the first and only over the counter fixed dose combination of acetaminophen (650 mg) and naproxen sodium... Read More

American Express Stock Falls 6% Despite Higher Q2 Earnings And Revenue

India, July 24 -- American Express Company (AXP) shares fell $20.87, or 6.12 percent, to $319.97 on Friday despite the financial services company reporting higher second-quarter earnings and revenue w... Read More

Vivakor Stock Jumps 45% After Expanding Crude Oil Marketing Platform

India, July 24 -- Vivakor, Inc. (VIVK) shares surged $0.97, or 45.75 percent, to $3.09 on Friday, after the company announced two new recurring physical crude oil commercial programs expected to gener... Read More

Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data

India, July 24 -- This week, the biotech sector was marked by FDA and EU approvals, strategic acquisitions, and a major workforce restructuring. Clinical trial updates delivered both breakthroughs and... Read More

Outlook Therapeutics Wins FDA Nod For LYTENAVA After Three Setbacks

India, July 24 -- Outlook Therapeutics (OTLK) announced that the FDA has approved LYTENAVA as the first and only FDA-approved ophthalmic formulation of bevacizumab for the treatment of neovascular age... Read More

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»